Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
Angelique N. Collamer, Daniel F. Battafarano
Seminars in Arthritis and Rheumatism (2010) Vol. 40, Iss. 3, pp. 233-240
Closed Access | Times Cited: 273

Showing 1-25 of 273 citing articles:

Risk Factors for the Development of Psoriasis
Koji Kamiya, Megumi Kishimoto, Junichi Sugai, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4347-4347
Open Access | Times Cited: 488
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
Gert Van Assche, Axel Dignaß, Bernd Bokemeyer, et al.
Journal of Crohn s and Colitis (2012) Vol. 7, Iss. 1, pp. 1-33
Open Access | Times Cited: 458
New insights of T cells in the pathogenesis of psoriasis
Yihua Cai, Chris Fleming, Jun Yan
Cellular and Molecular Immunology (2012) Vol. 9, Iss. 4, pp. 302-309
Open Access | Times Cited: 359
Current knowledge on psoriasis and autoimmune diseases
Thomas S. McCormick, Nilmarie Ayala‐Fontanez, David Soler
Psoriasis Targets and Therapy (2016), pp. 7-7
Open Access | Times Cited: 242
An update on generalized pustular psoriasis
Melinda Gooderham, Abby S. Van Voorhees, Mark Lebwohl
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 9, pp. 907-919
Open Access | Times Cited: 195
Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview
Éric Toussirot, F. Aubin
RMD Open (2016) Vol. 2, Iss. 2, pp. e000239-e000239
Open Access | Times Cited: 171
Psoriasis associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature
G Cullen, Daniela Kroshinsky, Adam S. Cheifetz, et al.
Alimentary Pharmacology & Therapeutics (2011) Vol. 34, Iss. 11-12, pp. 1318-1327
Open Access | Times Cited: 199
Biologics-induced autoimmune diseases
R. Pérez-Álvarez, M. Pérez-de-Lis, Manuel Ramos‐Casals
Current Opinion in Rheumatology (2012) Vol. 25, Iss. 1, pp. 56-64
Open Access | Times Cited: 168
Drug-induced psoriasis: clinical perspectives
Deepak M.W. Balak, Enes Hajdarbegovic
Psoriasis Targets and Therapy (2017) Vol. Volume 7, pp. 87-94
Open Access | Times Cited: 153
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
Christopher Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 2, pp. e3-e42
Open Access | Times Cited: 138
Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010
Eugenia Shmidt, David A. Wetter, Sara B. Ferguson, et al.
Journal of the American Academy of Dermatology (2011) Vol. 67, Iss. 5, pp. e179-e185
Closed Access | Times Cited: 124
Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience
E. Fréling, Cédric Baumann, Jean-François Cuny, et al.
The American Journal of Gastroenterology (2015) Vol. 110, Iss. 8, pp. 1186-1196
Closed Access | Times Cited: 119
Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases
Rafael Denadai, Fábio Vieira Teixeira, Flávio Steinwurz, et al.
Journal of Crohn s and Colitis (2012) Vol. 7, Iss. 7, pp. 517-524
Open Access | Times Cited: 115
Paradoxical effects of anti-TNF-α agents in inflammatory diseases
Daniel Wendling, Clément Prati
Expert Review of Clinical Immunology (2013) Vol. 10, Iss. 1, pp. 159-169
Closed Access | Times Cited: 109
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
Daniela Pugliese, Luisa Guidi, Pietro Manuel Ferraro, et al.
Alimentary Pharmacology & Therapeutics (2015) Vol. 42, Iss. 7, pp. 880-888
Open Access | Times Cited: 107
Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others
L. Puig
Current problems in dermatology (2017), pp. 49-63
Closed Access | Times Cited: 107
Adverse reactions to biologic agents and their medical management
Onur Boyman, Denis Comte, François Spertini
Nature Reviews Rheumatology (2014) Vol. 10, Iss. 10, pp. 612-627
Closed Access | Times Cited: 105
Shifting the focus – the primary role of IL‐23 in psoriasis and other inflammatory disorders
Melinda Gooderham, Kim Papp, Charles Lynde
Journal of the European Academy of Dermatology and Venereology (2018) Vol. 32, Iss. 7, pp. 1111-1119
Open Access | Times Cited: 98
Dermatological Manifestations in Inflammatory Bowel Diseases
Elisabetta Antonelli, Gabrio Bassotti, Marta Tramontana, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 364-364
Open Access | Times Cited: 98
TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management
Sara J. Li, Lourdes M. Pérez-Chada, Joseph F. Merola
Journal of Psoriasis and Psoriatic Arthritis (2018) Vol. 4, Iss. 2, pp. 70-80
Open Access | Times Cited: 95
Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis
Michael J. Murphy, Jeffrey M. Cohen, Matthew D. Vesely, et al.
Journal of the American Academy of Dermatology (2020) Vol. 86, Iss. 5, pp. 1080-1091
Closed Access | Times Cited: 93
Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research
Awais Ahmad, Nabisab Mujawar Mubarak, Khalida Naseem, et al.
Arabian Journal of Chemistry (2020) Vol. 13, Iss. 12, pp. 8935-8964
Open Access | Times Cited: 78
Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions
Kacey L. Sachen, C Greving, Jennifer E. Towne
Cytokine (2022) Vol. 156, pp. 155897-155897
Open Access | Times Cited: 65
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options
Carlo Alberto Maronese, Mario Valenti, Chiara Moltrasio, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2364-2376
Closed Access | Times Cited: 10
Etiopathogenesis of Psoriasis: Integration of Proposed Theories
Brenda Fernanda Hernandez-Nicols, Juan José Robledo-Pulido, Anabell Alvarado‐Navarro
Immunological Investigations (2024) Vol. 53, Iss. 3, pp. 348-415
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top